Contact Us

New Stories

• OncoSil Medical appoints as chief financial officer

  March 18, 2025 - - Latest News

• Nyrada commences recruitment for phase one clinical trial

  March 18, 2025 - - Latest News

• Neurizon Therapeutics updates investors on initiatives to lift clinical hold

  March 18, 2025 - - Latest News

• Race secures ethics approval for RC220 Phase 1 solid tumour trial

  March 18, 2025 - - Latest News

• Radiopharm Theranostics says new data confirms positive tumour uptake

  March 18, 2025 - - Latest News

• Telix completes the acquisition of FAP-targeting theranostic candidates

  March 13, 2025 - - Latest News

• Argent BioPharma signs exclusive agreement for Malta manufacturing facility

  March 13, 2025 - - Latest News